AGC (5201) Corporate Presentation summary
Event summary combining transcript, slides, and related documents.
Corporate Presentation summary
7 Jul, 2025Corporate overview and global presence
Headquartered in Tokyo, with 205 subsidiaries and 53,687 employees as of December 2024.
Operates in about 30 countries, with 194 consolidated subsidiaries, 156 of which are overseas.
Commands top global market share in float glass, automotive glass, and several specialty chemicals.
Extensive manufacturing and R&D network in Japan and worldwide.
Long corporate history dating back to 1907, with significant global expansion since the 1980s.
Product portfolio and innovation
Offers a wide range of glass products for architectural, automotive, and electronics applications.
Develops advanced energy-saving glass, photovoltaic-embedded glass, and safety/fire-resistant glass.
Supplies high-performance specialty glass for displays, touchscreens, and automotive interiors.
Manufactures essential and performance chemicals, including caustic soda, PVC, fluoropolymers, and silica.
Expands into new businesses such as high-speed communication solutions and advanced ceramics.
Key business segments
Architectural glass: Float, laminated, insulated, Low-E, decorative, and photovoltaic glass.
Automotive: Laminated, tempered, UV/IR cut, sound insulation, and smart glass for vehicles.
Electronics: Glass substrates for TFT-LCD/OLED, specialty glass for chemical strengthening, and optoelectronic materials.
Chemicals: Essential chemicals (caustic soda, PVC, polyols) and performance chemicals (fluoropolymers, electrolytes, coatings).
Life science: CDMO services for pharmaceuticals and biopharmaceuticals, with global cGMP operations.
Latest events from AGC
- Operating profit and ROE improved; FY2026 targets higher growth led by Life Science recovery.5201
Q4 20256 Feb 2026 - Targets 8% ROE and 10% ROCE by 2026, focusing on growth, reforms, and sustainability.5201
IR Day 2024 Day 231 Jan 2026 - 8% ROE and 440bn yen EBITDA targeted for 2026 via transformation and disciplined investment.5201
IR Day 2024 Day 131 Jan 2026 - Operating and net profit improved despite lower sales, with stable outlook and dividends.5201
Q3 20255 Nov 2025 - Targets net zero carbon by 2050, driven by innovation, ESG, and talent development.5201
ESG Update26 Sep 2025 - FY2025 outlook cut as Chemicals, Life Science, and Electronics underperform; profit rebounds.5201
Q2 20251 Aug 2025 - Ambidextrous strategy and sustainability drive growth, digitalization, and profitability targets.5201
Company Presentation7 Jul 2025 - Life Science impairments and Russian exit led to a sharp H1 2024 net loss despite sales growth.5201
Q2 202413 Jun 2025 - Sales rose, but major impairments and Russian exit drove a sharp net loss.5201
Q3 202413 Jun 2025